Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $912,870 - $1.15 Million
12,600 Added 53.62%
36,100 $2.9 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $227,472 - $272,636
-2,800 Reduced 10.65%
23,500 $1.94 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $762,268 - $913,244
10,700 Added 68.59%
26,300 $2.24 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $604,425 - $694,575
-7,500 Reduced 32.47%
15,600 $1.33 Million
Q3 2023

Nov 14, 2023

BUY
$82.56 - $93.49 $726,528 - $822,712
8,800 Added 61.54%
23,100 $2.07 Million
Q2 2023

Aug 14, 2023

SELL
$80.84 - $89.45 $331,444 - $366,745
-4,100 Reduced 22.28%
14,300 $1.22 Million
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $894,825 - $1.11 Million
12,300 Added 201.64%
18,400 $1.52 Million
Q4 2022

Feb 14, 2023

SELL
$73.85 - $86.14 $553,875 - $646,050
-7,500 Reduced 55.15%
6,100 $479,000
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $101,280 - $125,856
1,600 Added 13.33%
13,600 $1.01 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.